Skip to main content
Have a personal or library account? Click to login
Global, Regional, and National Burden of COPD Among Women from 1990 to 2021 and Projections to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021 Cover

Global, Regional, and National Burden of COPD Among Women from 1990 to 2021 and Projections to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021

Open Access
|Oct 2025

References

  1. Global initiative for chronic obstructive lung disease. GOLD Report. 2024. Accessed September 17, 2024. https://goldcopd.org/2024-gold-report/.
  2. GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):21002132.
  3. Ntritsos G, Franek J, Belbasis L, et al. Gender‑specific estimates of COPD prevalence: A systematic review and meta‑analysis. Int J Chron Obstruct Pulmon Dis. 2018;13:15071514.
  4. Celli BR, Wedzicha JA. Update on clinical aspects of chronic obstructive pulmonary disease. N Engl J Med. 2019;381:12571266.
  5. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:21632196.
  6. Landis SH, Muellerova H, Mannino DM, et al. Continuing to confront COPD international patient survey: Methods, copd prevalence, and disease burden in 2012–2013. Int J Chron Obstruct Pulmon Dis. 2014;9:597611.
  7. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): A population‑based prevalence study. Lancet. 2007;370:741750.
  8. Jenkins CR, Chapman KR, Donohue JF, Roche N, Tsiligianni I, Han MK. Improving the management of COPD in women. Chest. 2017;151:686696.
  9. Perez TA, Castillo EG, Ancochea J, et al. Sex differences between women and men with COPD: A new analysis of the 3CIA study. Respir Med. 2020;171:106105.
  10. López‑Campos JL, Ruiz‑Ramos M, Soriano JB. Mortality trends in chronic obstructive pulmonary disease in Europe, 1994–2010: A joinpoint regression analysis. Lancet Respir Med. 2014;2:5462.
  11. Safiri S, Carson‑Chahhoud K, Noori M, et al. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990–2019: Results from the Global Burden of Disease Study 2019. BMJ. 2022;378:e069679.
  12. IHME. Global Health Data Exchange. 2021. Accessed 2024. http://ghdx.healthdata.org/.
  13. IHME. GBD Results. 2021. Accessed 2024. https://vizhub.healthdata.org/gbd-results/.
  14. WHO. GATHER Checklist. 2023. https://www.who.int/publications/m/item/gather-checklist.
  15. IHME. Global Burden of Disease Study 2019 (GBD 2019) Socio‑Demographic Index (SDI) 1950–2019. 2019. https://ghdx.healthdata.org/search/site/SDI.
  16. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:12041222.
  17. Moreno‑Ternero JD, Platz TT, Østerdal LP. QALYs, DALYs, and HALYs: A unifying framework for the evaluation of population health. J Health Econ. 2023;87:102714.
  18. Knoll M, Furkel J, Debus J, Abdollahi A, Karch A, Stock C. An R package for an integrated evaluation of statistical approaches to cancer incidence projection. BMC Med Res Methodol. 2020;20:257.
  19. GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability‑adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5:691706.
  20. World Health Organization. “WHO Calls on Governments to Include Smoking Cessation in Tobacco Control Strategies.” 2003. Accessed September 30, 2024. www.who.int/news/item/06-08-2003-who-calls-on-governments-to-include-smoking-cessation-in-tobacco-control-strategies.
  21. United States Public Health Service Office of the Surgeon General, National Center for Chronic Disease Prevention and Health Promotion (US). Office on Smoking and Health. Smoking Cessation: A Report of the Surgeon General. US Department of Health and Human Services; 2020. PMID: 32255575.
  22. Tashkin DP. Smoking cessation in chronic obstructive pulmonary disease. Semin Respir Crit Care Med. 2015;36:491507.
  23. Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: The gold science committee report 2019. Eur Respir J. 2019;53:1900164.
  24. de Miguel‑Díez J, Hernández‑Vázquez J, López‑de‑Andrés A, Álvaro‑Meca A, Hernández‑Barrera V, Jiménez‑García R. Analysis of environmental risk factors for chronic obstructive pulmonary disease exacerbation: A case‑crossover study (2004–2013). PloS One. 2019;14:e0217143.
  25. Wedzicha JA, Seemungal TA. COPD exacerbations: Defining their cause and prevention. Lancet. 2007;370:786796.
  26. Bilano V, Gilmour S, Moffiet T, et al. Global trends and projections for tobacco use, 1990‑2025: An analysis of smoking indicators from the WHO comprehensive information systems for tobacco control. Lancet. 2015;385:966976.
  27. World Health Organization. WHO Global Report on Trends in Prevalence of Tobacco Use 2000–2030. 2024. Accessed October 15, 2024. www.who.int/publications/i/item/9789240088283.
  28. Liu N, Liu W, Deng F, et al. The burden of disease attributable to indoor air pollutants in China from 2000 to 2017. Lancet Planet Health. 2023;7:e900e911.
  29. Gut‑Gobert C, Cavaillès A, Dixmier A, et al. Women and COPD: Do we need more evidence? Eur Respir Rev. 2019;28:180055.
  30. Pleasants RA, Riley IL, Mannino DM. Defining and targeting health disparities in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2016;11:24752496.
  31. Miravitlles M, Vogelmeier C, Roche N, et al. A review of national guidelines for management of COPD in Europe. Eur Respir J. 2016;47:625637.
  32. GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:19231994.
  33. Langhammer A, Johnsen R, Holmen J, Gulsvik A, Bjermer L. Cigarette smoking gives more respiratory symptoms among women than among men. The Nord‑Trondelag Health Study (HUNT). J Epidemiol Community Health. 2000;54:917922.
  34. Varkey AB. Chronic obstructive pulmonary disease in women: Exploring gender differences. Curr Opin Pulm Med. 2004;10:98103.
DOI: https://doi.org/10.5334/aogh.4883 | Journal eISSN: 2214-9996
Language: English
Submitted on: Jul 24, 2025
Accepted on: Sep 16, 2025
Published on: Oct 27, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2025 Shiyu Hu, Hao Chen, Jiaye Wang, Ye Zhang, Chengshui Chen, Ye Zhang, Wenyu Chen, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.